|
|
|
|
|
Natraceutical’s shareholders are called to attend the Company’s Ordinary General Meeting, to be held on May 30
(125,11 Kb)
|
|
|
|
|
|
|
Natraceutical closed the first quarter of 2013 with a net profit growth of 38%, to 2.88 M€
(195,18 Kb)
|
|
|
|
|
|
|
Following the divestment of Naturex and the full repayment of the debt Natraceutical is now fully focused in Forté Pharma after closing 2012 with a clear operating improvement
(137,08 Kb)
|
|
|
|
|
|
List of the resutls notes posting dates for 2013
(55,12 Kb)
|
|
|
|
|
|
|
Natraceutical concludes its divestment in Naturex and will cancel its syndicated loan before maturity
(93,54 Kb)
|
|
|
|
